{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:06Z","timestamp":1786998306142,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["CA 27469"],"award-info":[{"award-number":["CA 27469"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["CA 37517"],"award-info":[{"award-number":["CA 37517"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ygyno.2010.10.018","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T04:10:39Z","timestamp":1289794239000},"page":"224-228","source":"Crossref","is-referenced-by-count":46,"title":["Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group"],"prefix":"10.1016","volume":"120","author":[{"given":"Charles A.","family":"Kunos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Sill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Buekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Schilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Diane","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mohiuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Fracasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.10.018_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0010","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.1998.16.1.159","article-title":"A phase I study of docetaxel with concomitant thoracic radiation therapy","volume":"16","author":"Mauer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0020","first-page":"19","article-title":"Weekly administration of docetaxel (Taxotere): summary of clinical data","volume":"26","author":"Hainsworth","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0025","first-page":"837","article-title":"Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum","volume":"2","author":"Kavanagh","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0030","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0959-8049(97)00363-8","article-title":"Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer\u2014an updated overview","volume":"33","author":"Kaye","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0035","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1200\/JCO.2000.18.14.2733","article-title":"Docetaxel for patients with paclitaxel-resistant Mullerian carcinoma","volume":"18","author":"Verschraegen","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0090-8258(02)00091-4","article-title":"A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study","volume":"88","author":"Rose","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0045","series-title":"Radiobiology for the Radiologist, Vol","first-page":"341","article-title":"Clinical response of normal tissues","author":"Hall","year":"2006"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0360-3016(95)00252-9","article-title":"Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer","volume":"34","author":"Randall","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/0360-3016(93)90463-6","article-title":"Salvage whole abdomen radiation therapy: its role in ovarian cancer","author":"Reddy","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0060","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0360-3016(91)90743-N","article-title":"Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma","volume":"21","author":"Eifel","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0065","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B","article-title":"Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure","volume":"74","author":"Corn","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9378(79)90950-5","article-title":"Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation","volume":"134","author":"Dembo","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(03)00510-8","article-title":"High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: Long-term toxicity and outcomes","volume":"57","author":"Firat","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0080","first-page":"891893","article-title":"Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53","author":"Chendil","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0085","series-title":"Radiobiology for the Radiologist, Vol","first-page":"378","article-title":"Time, dose, and fractionation in radiotherapy","author":"Hall","year":"2006"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0090","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1023\/A:1008399712913","article-title":"Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration","volume":"10","author":"Briasoulis","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0100","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijrobp.2003.09.019","article-title":"Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm","volume":"58","author":"Arnold","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/humrep\/deg016","article-title":"The radiosensitivity of the human oocyte","volume":"18","author":"Wallace","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmn063","article-title":"The current knowledge on radiosensitivity of ovarian follicle development stages","volume":"15","author":"Adriaens","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0115","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1006\/gyno.1994.1344","article-title":"Radiotherapy in early ovarian cancer","volume":"55","author":"Thomas","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0120","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0360-3016(92)90777-F","article-title":"Epithelial ovarian cancer: the role of radiotherapy","volume":"22","author":"Dembo","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2010.10.018_bb0125","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ejca.2009.01.006","article-title":"Long-term morbidity of adjuvant whole-abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer","volume":"45","author":"Engelen","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581000764X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581000764X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T04:47:58Z","timestamp":1559796478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581000764X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S009082581000764X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.10.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}